Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
1.21 (USD) • At close May 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 26.865 | 0 | 0 | 40.56 | 2.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.317 | 0 | 0.327 | 0.324 | 0.337 | 0.348 | 0.344 | 0.36 | 0.359 | 0.375 | 0.348 | 0.344 | 0.209 | 0.137 | 0.119 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 26.548 | 0 | -0.327 | 40.236 | 1.767 | -0.348 | -0.344 | -0.36 | -0.359 | -0.375 | -0.348 | -0.344 | -0.209 | -0.137 | -0.119 | -0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.988 | 0 | 0 | 0.992 | 0.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 27.247 | 32.973 | 36.824 | 48.386 | 49.585 | 51.557 | 46.765 | 42.684 | 48.584 | 40.616 | 42.181 | 43.825 | 46.112 | 38.439 | 53.998 | 44.77 | 38.394 | 29.521 | 24.67 | 17.452 | 13.258 | 11.869 | 10.739 | 8.689 | 7.089 |
| General & Administrative Expenses
| 10.58 | 40.005 | 14.608 | 16.762 | 15.74 | 16.365 | 15.953 | 15.664 | 16.369 | 11.138 | 12.012 | 19.636 | 11.767 | 9.754 | 8.872 | 10.362 | 11.953 | 10.724 | 10.097 | 9.924 | 3.141 | 3.036 | 1.844 | 1.946 | 1.633 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | -0.324 | -0.337 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.58 | 40.005 | 14.608 | 16.762 | 15.416 | 16.028 | 15.953 | 15.664 | 16.369 | 11.138 | 12.012 | 19.636 | 11.767 | 9.754 | 8.872 | 10.362 | 11.953 | 10.724 | 10.097 | 9.924 | 3.141 | 3.036 | 1.844 | 1.946 | 1.633 |
| Other Expenses
| 7.796 | 3.736 | 0 | 0 | 0 | 0 | 0 | 45.568 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.012 |
| Operating Expenses
| 45.623 | 76.714 | 51.432 | 65.148 | 65.001 | 67.585 | 62.718 | 58.348 | 64.953 | 51.754 | 54.193 | 63.461 | 57.879 | 48.193 | 62.87 | 55.132 | 50.347 | 40.245 | 34.767 | 27.376 | 16.399 | 14.905 | 12.583 | 10.635 | 8.722 |
| Operating Income
| -45.623 | -49.849 | -51.432 | -65.148 | -24.765 | -67.922 | -62.718 | -103.916 | -64.953 | -51.754 | -54.193 | -63.461 | -57.879 | -48.193 | -62.87 | -55.132 | -50.347 | -40.245 | -34.767 | -27.376 | -16.399 | -14.905 | -12.583 | -10.635 | -8.722 |
| Operating Income Ratio
| 0 | -1.856 | 0 | 0 | -0.611 | -32.282 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.656 | 2.172 | 11.247 | -22.863 | 34.948 | 6.848 | 7.209 | -41.117 | 4.109 | 3.232 | 1.905 | 0.424 | 0.426 | 0.088 | 51.681 | 0.115 | 0.099 | 0.315 | 0.12 | 0.084 | 0.164 | 0.359 | 0.012 | 0.049 | 0.062 |
| Income Before Tax
| -48.279 | -47.677 | -40.185 | -88.011 | 10.183 | -61.074 | -55.509 | -99.465 | -60.844 | -48.522 | -52.288 | -63.037 | -57.453 | -48.105 | -11.189 | -55.017 | -50.248 | -39.93 | -34.647 | -27.292 | -16.235 | -14.546 | -12.571 | -10.586 | -8.66 |
| Income Before Tax Ratio
| 0 | -1.775 | 0 | 0 | 0.251 | -29.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.205 | -0.027 | 0.266 | 0.143 | -0.135 | 0.031 | -0.605 | 0.108 | -0.36 | -0.159 | 0.017 | 0.033 | 0.159 | -0.697 | 0.045 | 0.196 | 0.426 | 0.018 | -0.435 | -0.109 | -0.538 | 0.001 | 0.011 | 0.003 |
| Net Income
| -48.279 | -47.472 | -40.158 | -88.277 | 10.068 | -60.917 | -55.528 | -112.527 | -60.952 | -48.162 | -52.129 | -63.054 | -57.486 | -50.059 | -4.191 | -54.574 | -49.901 | -40.303 | -34.555 | -26.857 | -16.126 | -14.506 | -12.344 | -10.47 | -8.343 |
| Net Income Ratio
| 0 | -1.767 | 0 | 0 | 0.248 | -28.953 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.094 | -1.34 | -1.24 | -1.01 | -0.91 | -0.78 | -0.47 | -0.44 | -0.68 | -0.58 | -0.46 |
| EPS Diluted
| -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.094 | -1.34 | -1.24 | -1.01 | -0.91 | -0.78 | -0.47 | -0.42 | -0.68 | -0.58 | -0.46 |
| EBITDA
| -45.623 | -45.796 | -51.111 | -65.148 | -24.441 | -67.585 | -62.37 | -58.004 | -64.593 | -51.395 | -53.818 | -63.113 | -57.535 | -47.896 | -62.733 | -55.013 | -50.268 | -40.212 | -34.716 | -27.338 | -16.361 | -14.864 | -12.558 | -10.611 | -8.701 |
| EBITDA Ratio
| 0 | -1.705 | 0 | 0 | -0.603 | -32.122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |